Hepatitis C - Virology and future antiviral targets

American Journal of Medicine

Volumn 107, Issue 6 SUPPL. 2, 1999, Pages 45-48

  Di Bisceglie, Adrian M ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CAPSID PROTEIN; CD81 ANTIGEN; CORE PROTEIN; ENVELOPE PROTEIN; HELICASE; PROTEINASE INHIBITOR; RNA DIRECTED RNA POLYMERASE; VIRUS RECEPTOR;

CONFERENCE PAPER; DRUG RESEARCH; DRUG TARGETING; GENE EXPRESSION; GENOTYPE; HEPATITIS C VIRUS; HUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN ANALYSIS; RNA STRUCTURE; SEQUENCE ANALYSIS; UNTRANSLATED REGION; VIRUS GENOME; VIRUS PARTICLE;

EID: 0033382088     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(99)00381-2     Document Type: Conference Paper

References (6)

1. Reed K.E., Rice C.M. Molecular characterization of hepatitis C virus. Reesink H.W. Hepatitis C Virus. 2nd ed. 1998;1-37 Karger, Basel.
2. Love R.A., Parge H.E., Wickersham J.A., et al. The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell. 87:1996;331-342.
3. Kim J.L., Morgenstern K.A., Griffith J.P., et al. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide the crystal structure provides insights into the modes of unwinding . Structure. 6:1998;89-100.
4. Pileri P., Uematsu Y., Campagnoli S., et al. Binding of hepatitis C virus to CD81. Science. 282:1998;938-941.
5. Das S., Ott M., Yamane A., et al. A small yeast RNA blocks hepatitis C virus internal ribosomal entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element. J Virol. 72:1998;5638-5647.
6. Caselmann W.H., Eisenhardt S., Alt M. Synthetic antisense oligodeoxynucleotides as potential drugs against hepatitis C. Intervirology. 40:1997;394-399.